CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications.

@article{Uber2004CD3MA,
  title={CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications.},
  author={Walter E. Uber and Lynn A Uber and Adrian Vanbakel and Arthur Jackson Crumbley and Naveen Pereira and John S. Ikonomidis and Daniele S Feldman},
  journal={Transplantation proceedings},
  year={2004},
  volume={36 10},
  pages={3245-9}
}
INTRODUCTION CD3 monitoring of antithymocyte globulin therapy in renal transplantation has been shown to be more cost-effective than standard regimens. The objective of this study was to evaluate CD3 monitoring with Thymoglobulin in cardiac transplantation. METHODS Cardiac transplant patients who required antithymocyte globulin therapy were dose-adjusted to maintain absolute CD3 counts <25 cells/microL. Endomyocardial biopsies and hemodynamic parameters were used to assess efficacy. The… CONTINUE READING

Similar Papers

Loading similar papers…